サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1105595

ヒトパピローマウイルスワクチンの世界市場規模調査：タイプ別（二価、四価、九価）、適応症別（子宮頸がん、肛門がん、陰茎がん、中咽頭がん、性器いぼ、その他）、地域別予測（2022年～2028年）

Global Human Papillomavirus Vaccine Market Size study, by Type (Bivalent, Quadrivalent, Nonavalent), Indication (Cervical Cancer, Anal Cancer, Penile Cancer, Oropharyngeal Cancer, Genital Warts, and Others), and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ヒトパピローマウイルスワクチンの世界市場規模調査：タイプ別（二価、四価、九価）、適応症別（子宮頸がん、肛門がん、陰茎がん、中咽頭がん、性器いぼ、その他）、地域別予測（2022年～2028年）
出版日: 2022年07月04日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトパピローマウイルスワクチンの市場規模は、予測期間（2022年～2028年）中に7.5％以上のCAGRで成長すると予測されています。

政府機関や民間企業による早期検診やワクチン接種の取り組みの増加、新しいHPVワクチンの承認は、ヒトパピローマウイルスワクチン市場の成長を促進しています。しかし、厳しい規制が市場の成長を抑制しています。

当レポートでは、世界のヒトパピローマウイルスワクチン市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のヒトパピローマウイルスワクチン市場の定義と範囲

第3章 世界のヒトパピローマウイルスワクチン市場力学

  • ヒトパピローマウイルスワクチン市場の影響分析（2020年～2028年）

第4章 世界のヒトパピローマウイルスワクチン市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-COVID-19以後の市場シナリオ

第6章 世界のヒトパピローマウイルスワクチン市場：タイプ別

  • 市場スナップショット
  • 世界のヒトパピローマウイルスワクチン市場実績－潜在分析：タイプ別
  • 世界のヒトパピローマウイルスワクチン市場の推定と予測（100万米ドル）（2018年～2028年）：タイプ別
  • ヒトパピローマウイルスワクチン市場、サブセグメント分析
    • 二価
    • 四価
    • 九価

第7章 世界のヒトパピローマウイルスワクチン市場：適応症別

  • 市場スナップショット
  • 世界のヒトパピローマウイルスワクチン市場実績－潜在分析：適応症別
  • 世界のヒトパピローマウイルスワクチン市場の推定と予測（100万米ドル）（2018年～2028年）：適応症別
  • ヒトパピローマウイルスワクチン市場、サブセグメント分析
    • 子宮頸がん
    • 肛門がん
    • 陰茎がん
    • 中咽頭がん
    • 性器いぼ
    • その他

第8章 世界のヒトパピローマウイルスワクチン市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Serum Institute of India Pvt. Ltd.
    • Merck & Co., Inc.,
    • Walvax Biotechnology Co., Ltd
    • GlaxoSmithKline Plc
    • Wantai BioPharm
    • INOVIO Pharmaceuticals

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Human Papillomavirus Vaccine Market, report scope
  • TABLE 2. Global Human Papillomavirus Vaccine Market estimates & forecasts by region 2018-2028 (USD Million)
  • TABLE 3. Global Human Papillomavirus Vaccine Market estimates & forecasts by Type 2018-2028 (USD Million)
  • TABLE 4. Global Human Papillomavirus Vaccine Market estimates & forecasts by Indication 2018-2028 (USD Million)
  • TABLE 5. Global Human Papillomavirus Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Human Papillomavirus Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Human Papillomavirus Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Human Papillomavirus Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Human Papillomavirus Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Human Papillomavirus Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Human Papillomavirus Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Human Papillomavirus Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Human Papillomavirus Vaccine Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Human Papillomavirus Vaccine Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Human Papillomavirus Vaccine Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Human Papillomavirus Vaccine Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Human Papillomavirus Vaccine Market
  • TABLE 55. List of primary sources, used in the study of global Human Papillomavirus Vaccine Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Papillomavirus Vaccine Market, research methodology
  • FIG 2. Global Human Papillomavirus Vaccine Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Human Papillomavirus Vaccine Market, key trends 2021
  • FIG 5. Global Human Papillomavirus Vaccine Market, growth prospects 2022-2028
  • FIG 6. Global Human Papillomavirus Vaccine Market, porters 5 force model
  • FIG 7. Global Human Papillomavirus Vaccine Market, pest analysis
  • FIG 8. Global Human Papillomavirus Vaccine Market, value chain analysis
  • FIG 9. Global Human Papillomavirus Vaccine Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Human Papillomavirus Vaccine Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Human Papillomavirus Vaccine Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Human Papillomavirus Vaccine Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Human Papillomavirus Vaccine Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Human Papillomavirus Vaccine Market, regional snapshot 2018 & 2028
  • FIG 15. North America Human Papillomavirus Vaccine Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Human Papillomavirus Vaccine Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Human Papillomavirus Vaccine Market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Human Papillomavirus Vaccine Market 2018 & 2028 (USD Million)
  • FIG 19. Global Human Papillomavirus Vaccine Market, company market share analysis (2021)
目次

Global Human Papillomavirus Vaccine Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2022-2028. The virus known as the human papillomavirus (HPV) spreads through interaction with others who have the same complexion. There are more than 100 different forms of HPV, over 40 of which have been sexually transmitted and can harm your genital area, mouth, or neck. According to the Centers for Disease Control and Prevention (CDC), HPV is the most common illness. Because it is so common, even those who have few sexual partners may eventually get some of its many forms. The market growth driven by key factors such as increasing initiatives by Government & Private Organizations for Early Screening & Vaccination and approval of New HPV Vaccines. According to data published by UNICEF in 2018, the organisation received more than 12.9 million doses of the human papillomavirus (HPV) vaccination between 2013 and 2017. Additionally, UNICEF procured 16 percent of doses for self-financing middle-income countries and 84 percent of doses for Gavi, the Vaccine Alliance (Gavi)-supported nations (MICs). Furthermore, Cancer is the second most prevalent cause of cancer-related mortality globally, accounting for about 300,000 fatalities yearly, according to the WHO. It is also the third most common disease in women. Therefore, the market is anticipated to see rapid expansion throughout the projected period because of the growing incidence of cervical cancer. However, stringent Regulation impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Human Papillomavirus Vaccine Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is dominating the market growth owing to stringent Regulation and rising cases are expected to boost the growth of the market. On the other side, APAC is the fastest growing region due to increase in major companies' investments in setting up vaccine manufacturing units and increase in major companies' investments in setting up vaccine manufacturing units.

Major market players included in this report are:

Merck & Co., Inc.,

Walvax Biotechnology Co., Ltd

GlaxoSmithKline Plc

Wantai BioPharm

INOVIO Pharmaceuticals

Serum Institute of India Pvt. Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Bivalent

Quadrivalent

Nonavalent

By Indication:

Cervical Cancer

Anal Cancer

Penile Cancer

Oropharyngeal Cancer

Genital Warts

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Human Papillomavirus Vaccine Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Human Papillomavirus Vaccine Market, by region, 2020-2028 (USD Million)
    • 1.2.2. Human Papillomavirus Vaccine Market, by Type, 2020-2028 (USD Million)
    • 1.2.3. Human Papillomavirus Vaccine Market, by Indication, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Papillomavirus Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Papillomavirus Vaccine Market Dynamics

  • 3.1. Human Papillomavirus Vaccine Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing initiatives by Government & Private Organizations for Early Screening & Vaccination
      • 3.1.1.2. Approval of New HPV Vaccines
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent Regulation
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Efficiency of HPV vaccine

Chapter 4. Global Human Papillomavirus Vaccine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Human Papillomavirus Vaccine Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Human Papillomavirus Vaccine Market by Type, Performance - Potential Analysis
  • 6.3. Global Human Papillomavirus Vaccine Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
  • 6.4. Human Papillomavirus Vaccine Market, Sub Segment Analysis
    • 6.4.1. Bivalent
    • 6.4.2. Quadrivalent
    • 6.4.3. Nonavalent

Chapter 7. Global Human Papillomavirus Vaccine Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Human Papillomavirus Vaccine Market by Indication, Performance - Potential Analysis
  • 7.3. Global Human Papillomavirus Vaccine Market Estimates & Forecasts by Indication, 2018-2028 (USD Million)
  • 7.4. Human Papillomavirus Vaccine Market, Sub Segment Analysis
    • 7.4.1. Cervical Cancer
    • 7.4.2. Anal Cancer
    • 7.4.3. Penile Cancer
    • 7.4.4. Oropharyngeal Cancer
    • 7.4.5. Genital Warts
    • 7.4.6. Others

Chapter 8. Global Human Papillomavirus Vaccine Market, Regional Analysis

  • 8.1. Human Papillomavirus Vaccine Market, Regional Market Snapshot
  • 8.2. North America Human Papillomavirus Vaccine Market
    • 8.2.1. U.S. Human Papillomavirus Vaccine Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Indication breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Human Papillomavirus Vaccine Market
  • 8.3. Europe Human Papillomavirus Vaccine Market Snapshot
    • 8.3.1. U.K. Human Papillomavirus Vaccine Market
    • 8.3.2. Germany Human Papillomavirus Vaccine Market
    • 8.3.3. France Human Papillomavirus Vaccine Market
    • 8.3.4. Spain Human Papillomavirus Vaccine Market
    • 8.3.5. Italy Human Papillomavirus Vaccine Market
    • 8.3.6. Rest of Europe Human Papillomavirus Vaccine Market
  • 8.4. Asia-Pacific Human Papillomavirus Vaccine Market Snapshot
    • 8.4.1. China Human Papillomavirus Vaccine Market
    • 8.4.2. India Human Papillomavirus Vaccine Market
    • 8.4.3. Japan Human Papillomavirus Vaccine Market
    • 8.4.4. Australia Human Papillomavirus Vaccine Market
    • 8.4.5. South Korea Human Papillomavirus Vaccine Market
    • 8.4.6. Rest of Asia Pacific Human Papillomavirus Vaccine Market
  • 8.5. Latin America Human Papillomavirus Vaccine Market Snapshot
    • 8.5.1. Brazil Human Papillomavirus Vaccine Market
    • 8.5.2. Mexico Human Papillomavirus Vaccine Market
  • 8.6. Rest of The World Human Papillomavirus Vaccine Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Serum Institute of India Pvt. Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Merck & Co., Inc.,
    • 9.2.3. Walvax Biotechnology Co., Ltd
    • 9.2.4. GlaxoSmithKline Plc
    • 9.2.5. Wantai BioPharm
    • 9.2.6. INOVIO Pharmaceuticals

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption